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Background: Iron oxidation is thought to be predominantly handled enzymatically in the body, to minimize
spontaneous combustion with oxygen and to facilitate cellular iron export by loading transferrin. This process
may be impaired in disease, and requires more accurate analytical assays to interrogate enzymatic- and auto-
oxidation within a physiologically relevant environment.
Method: A new triplex ferroxidase activity assay has been developed that overcomes the previous assay
limitations of measuring iron oxidation at a physiologically relevant pH and salinity.
Results: Revised enzymatic kinetics for ceruloplasmin (Vmax≈ 35 μM Fe3+/min/μM; Km≈ 15 μM) are provided
under physiological conditions, and inhibition by sodium azide (Ki for Ferric Gain 78.3 μM, Ki for transferrin
loading 8.1 × 104 μM) is quantiﬁed. We also used this assay to characterize the non-enzymatic oxidation of
iron that proceeded linearly under physiological conditions.
Conclusions and general signiﬁcance: These ﬁndings indicate that the requirement of an enzyme to oxidize iron
may only be necessary under conditions of adverse pH or anionic strength, for example fromhypoxia. In a normal
physiological environment, Fe3+ incorporation into transferrin would be sufﬁciently enabled by the biological
polyanions that are prevalent within extracellular ﬂuids.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Iron is an essential element for most forms of life, however iron
overload can be toxic. The ability for iron to undergo redox cycling in
physiological conditions underlies both its biochemical utility, and its
potential hazard. Iron transitions in active sites from and to ferric
(Fe3+) and ferrous (Fe2+) forms [1,2] to catalyze enzymatic processes.
However, this versatility can also have potentially detrimental effects
where free Fe2+ and Fe3+ ions partake in Haber–Weiss [3] and Fenton
[4] redox reactions to generate chemically reactive hydroxyl radicals
and superoxide that degrade lipids, proteins and nucleic acids [5–7].
Therefore, to prevent iron-induced toxicity, organisms that are iron-
dependent have protein chaperones and transporters to maintain iron
homeostasis, trafﬁcking and metabolism [8].
Ferroxidases are considered to play an important role in the efﬂux of
iron from cells. It is thought that exiting iron is in the ferrous state when
transported across the plasma membrane through the transmembrane
pore ferroportin (FPN). Upon reaching the extracellular surface, ironnd Cellular Biology, Faculty of
shire, United Kingdom.
), J.A.Duce@leeds.ac.uk
. This is an open access article undermust be oxidized to its Fe3+ state before being released from FPN and
being incorporated into the extracellular transport protein, transferrin
(TF). Traditionally multicopper ferroxidases such as ceruloplasmin
(CP) and hephaestin are considered to not only stabilize FPN on the
cell surface [9,10] but also utilize copper to oxidize iron and facilitate
efﬂux [11–13]. Evidence supporting this role formulticopper ferroxidases
was shown when perfused livers of copper-deﬁcient dogs and pigs that
had accumulated iron were treated with holo-CP resulting in immediate
release of iron into the periphery [14–16]. Humans [17] and rodents
[18] affected by aceruloplasminemia (absence of CP) accumulate iron,
but only slowly, indicating that iron export from tissue is handled
bymechanisms that might have some redundancy. One possible expla-
nation is that under conditions of adequate oxygenation, biological
polyanions such as citrate and phosphate can sufﬁciently promote
ferroxidation by altering the Fe2+/Fe3+ redox couple, without the
need for a ferroxidase [19]. Mammalian blood [20] and CSF [21] have
been reported to contain low molecular weight ferroxidation activities
that might reﬂect this chemistry [20,21]. This underscores a proposal
that ferroxidase enzymes like CP might only be needed under condi-
tions of hypoxic stress, where their low Km for O2 enables them to
promote ferroxidation where a polyanion cannot [19].
Consistentwith thepossibility that CP ismainly active under hypoxic
conditions, loss of CP activity has been reported in serum [22–27],the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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(3)
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(5)
3300 B.X. Wong et al. / Biochimica et Biophysica Acta 1840 (2014) 3299–3310cerebrospinal ﬂuid (CSF) [28–30], and brain [31–33] in Alzheimer's dis-
ease (AD) and Parkinson's disease (PD) conditions where oxidative
stress and hypoxia have been implicated. The inability of CP to be
recruited for the export of iron under hypoxic conditions may explain
the toxic accumulation of iron in the brain in these diseases [34–37].
While these ﬁndings argue that the study of ferroxidases in neurode-
generative diseasewarrants further attention, the tools for their study are
problematic. Ferroxidase activity is frequently measured by the
colorimetric assay developed by Osaki, Johnson and Frieden [2,38] that
requires Fe2+ and apo-TF as substrates and monitors spectroscopic
change to TF upon incorporation of Fe3+. Originally used to measure
‘ferroxidase I’ enzyme activity in serum, that was later determined to be
CP, this method has since been used to deﬁne the ferroxidase activity of
H-ferritin [39], hephaestin [40] and β-amyloid precursor protein [33].
Later colorimetric methods for measuring the oxidation of iron have
made use of Fe2+-speciﬁc chromogens such as ferrozine [40,41] and
ferene S [20,42]. Also, directmeasurement of Fe3+ spectrophotometrical-
ly has been performed to monitor the activity of ferroxidases [20,43,44].
Each of these assays has their own limitations and caveats. The “transfer-
rin assay” [38] is an indirect measure of ferroxidase activity that could be
restricted by the loading rate of Fe3+ onto apo-TF instead of actual cata-
lytic oxidation activity. This is further complicated by TF also accelerating
the rate of reaction and possibly having oxidase activity itself [45]. The
“Ferrous Loss assay” [20,42] also indirectly measures ferroxidase activity
through selective chelation of the remaining Fe2+ with a chromagen,
e.g. ferene S. It cannot be used for kinetic measurements because it com-
peteswith the enzyme for Fe2+, thus inhibiting ferroxidation if present at
the beginning of the assay. The “Ferric Gain assay” [20,43,44] is the only
direct measurement of ferroxidase activity but uses an absorbancewave-
length of 310 nm to monitor Fe3+, which overlaps with the absorbance
spectra of many proteins. Most signiﬁcantly, the buffer used in the devel-
opment of each of these assays was pH≈ 6 sodium acetate (NaOAc), to
minimize auto-oxidation. Not only is NaOAc outside of its buffering
range at pH 6, but saline was also not adjusted to isotonic levels [2,20,
38,39,42] rendering these classical assay systems unsuitable for assessing
iron oxidation under physiological conditions.
In the current study, effort has been taken to design a method to
measure ferroxidase activity in a manner that combines the advantages
of each of these existing assays while utilizing our better present under-
standing of iron oxidation to remedy thedisadvantages of thepreviously
used parameters. The combined kinetic assay provides a more compre-
hensive representation of the ferroxidase activity within a physiological
environment and has enabled the characterization of the ferroxidase
activity of CP under physiologically relevant conditions, as well as the
inhibitory effects of sodium azide on its catalytic ferroxidase activity.
2. Experimental procedures
2.1. Reagents
Reagents were all of analytical grade and were purchased from
Sigma, Australia, unless otherwise stated.
2.2. Reagent preparations
Purity of human CP (Vital Products) and bovine serum albumin
(BSA)was enhanced by size exclusionwith a Superdex 200 10/GL ﬁltra-
tion column (GE Healthcare) and buffer-exchanged into either HBS
(HEPES 50 mM, NaCl 150 mM, pH 7.2) or double-distilled water
(ddH2O) by repeated washes through a 30 kDa cutoff Amicon Ultra-15
(Millipore) centrifugal ﬁlter unit, or by dialysis (Thermo Scientiﬁc)
with a 10 kDa cutoff membrane. Subsequent ﬂow-through or dialysis
buffer was used as the vehicle controls for the ferroxidase assay. The
buffer-exchanged proteins as well as human apo-transferrin (N98%
pure) dissolved in ddH2O were quantiﬁed through bicinchoninic acid
(BCA) assay (Pierce) according to the manufacturer's protocol.Ferrous ammonium sulfate or ferrous sulfate solution was prepared
by dissolving a known amount in N2-ﬂushed ddH2O immediately prior
to the commencement of experiments. The ferrous sulfate substrate
was used within a one hour period when auto-oxidation was still
observed as negligible (illustrated as ‘vehicle control’ in all ﬁgures).
2.3. Ferroxidase assays
A ferroxidase is an enzyme that catalyzes the oxidation of Fe2+ to
Fe3+ with the liberation of water from oxygen. Three previously
established procedures were adapted in a plate assay to spectrophoto-
metrically measure substrate (Fe2+) or products (Fe3+ and diferric
holo-TF) involved in the ferroxidase reaction.
2.4. ‘Ferrous Loss’ assay
Adapted from Erel et al. [42], the ﬁrst procedure measured Fe2+
consumption by loss of absorbance at 590 nm from selective Fe2+
binding to the chromogen ferene S. (Eqs. (1) and (2)):Fe2þ þ ferene S⇌Fe3þ : ferene S Abs590mmð Þ: ð2Þ
2.5. ‘Ferric Gain’ assay
The second procedure from Minotti and Ikeda-Saito [44] directly
measured Fe3+ conversion by change in 310 nm absorbance (Eq. (3)).2.6. TF loading assay
A third procedure adapted from Johnson et al. [2] as well as Bakker
and Boyer [39] followed the physiological loading of apo-TF with Fe3+
which resulted in a change of absorbance at 460 nm (Eq. (4) or (5)).orIn 200 μL reaction mixes (ﬁnal concentrations): enzyme (500 or
250 nM) was added to HBS (HEPES 50 mM, NaCl 150 mM, pH 7.2)
(unless otherwise stated) in the absence or presence of apo-TF
(50 μM). Either ferrous ammonium sulfate or ferrous sulfate (100 μM)
was able to be used as substrates for the assay and was dissolved in
N2-purged ddH2O just prior to addition. The substrate was added as
the last component of the assay to initiate the reaction. Absorbance
readings (310 nM and 460 nM) were monitored at 30 s intervals
over 4 min at 24 °C with agitation. Ferene S (500 μM) was added at
3301B.X. Wong et al. / Biochimica et Biophysica Acta 1840 (2014) 3299–3310the end of 4min, brieﬂy agitated and absorbance (590 nm)was read im-
mediately. For experiments involving enzyme rates the reactions were
monitored for 3 min when the ferroxidase reaction was still linear.
Refer to Figure S1 for the workﬂow of preparation of triplex assay.
Reactions were blanked against sample buffers (HBS) that had all
components in the reaction mix except the sample itself. Extinction
coefﬁcients of Fe were recalculated for the new assay as shown in
Table 1 on either the Flexstation 3 (Molecular Devices) or PowerWave
HT (BioTek) microplate spectrophotometer. Results were plotted and
statistically analyzed using a combination of Excel (2011, Microsoft)
and Prism (v5.0. GraphPad Software Inc.).
3. Results
Webegan the development of amultiple ferroxidase assay by exam-
ining the impact of various buffer conditions upon the TF loading assay,
with the aim to identify suitable solutions that could be applied to the
assay of candidate ferroxidase enzymes under physiological conditions
of pH and saline.
3.1. Adaptation of the transferrin loading assay
Spectral changes occurring during the TF loading reaction are illus-
trated in Fig. 1Ai–ii. After 10 min, only in the combined presence of
CP, TF and Fe2+ there is an increase in absorbance at 460 nm with all
other component controls giving negligible measurements at the same
wavelength.
Further assay development required only one component of the TF
loading assay to be investigated while all the other components were
kept constant according to themethods by Johnson et al. [2] and Bakker
and Boyer [39]. Increasing CP, apo-TF or Fe2+ resulted in increased rate
of Fe3+ formation, while increasing NaOAc buffer concentrations
decreased CP activity (Fig. 1B–E). These results indicate that, despite
the NaOAc buffer being outside its buffering range (pH 3.6–5.6) [46],
the conditions used previously [2,39] were still suitable for the TF
loading assay at pH 6, namely 100 mM NaOAc buffer, 250 nM CP;
50 μMapo-TF; and 100 μM ferrous ammonium sulfate or ferrous sulfate.
As the non-buffered environment currently used in the assay may
result in anomalous outcomes caused by iron auto-oxidation [47] alter-
native buffers within their buffering range were tested. The buffers,
including Good's buffers, were grouped into low pH (pH 5.5–6.0),
neutral pH (pH 7.0) and physiological (isotonic saline, pH 7.4)
(Fig. 2A–C). At low pH, NaOAc buffer at pH 5.5 provided the best perfor-
mance in the TF loading assay, while at neutral pH HEPES and PIPES
were the best candidates. In physiological conditions HEPES-buffered
saline (HBS) was best for measuring TF loading. CP activity in loading
TF was abolished by citrate buffer (Fig. 2B), potentially due to citrate
sequestering available iron from TF [45]. Interestingly, phosphate-
buffered saline (PBS) increased the overall rate of TF loading compared
to other buffer systems (Figs. 2C and S2), possibly because the phos-
phates presentwithin this buffer promote auto-oxidation by interacting
with Fe3+ ions and transferring them to TF [48].
Having identiﬁed the best working buffers within the experimental
conditions required for TF loading with minimal auto-oxidation, the
best pH within each buffering range was shown to be 5.5 for NaOAc,
6.5 for PIPES and 7.0 for HBS (Fig. 3A–C). To accurately measure ferrox-
idase activity, enzymatic rate should be much greater than the rate ofTable 1
Experimentally-derived extinction coefﬁcients for new ferroxidase assay.
Ferrous loss
(mM−1 Fe2+ cm−1)
Sodium acetate buffer, pH = 5.5 37.3
PIPES buffer, pH = 6.5 37.3
HBS, pH = 7.2 36.6auto-oxidation of Fe2+. CP had little to no ferroxidase activity when
pH was ≤5.0, but from pH 5.5 to 7.5, activity increased linearly
at 0.011 ± 0.001 AU/min/pH (r2 = 0.951) with a Vmax of 0.029 ±
0.001 AU/min (Fig. 3Di). However, the rate of iron auto-oxidation
increased markedly above pH 7.0 and reached a rate comparable to CP
enzymatic activity at pH8.0 (Fig. 3Di). Blanking the activity of CP against
the vehicle control highlighted the inﬂuence of pHon TF loading activity
and underscored the contribution of Fe2+ auto-oxidation to TF loading
at physiological pH. The usable pH range for TF loading assay was
5.5–7.5, optimally pH 7.2 to discern the contribution of CP above such
auto-oxidation (Fig. 3Dii).
The effect of salinity was investigated by NaCl titration in 50 mM
HEPES buffer pH 7.2, representing physiological pH. Increasing salinity
from 0–200 mM had minimal effect on the TF loading ferroxidase
activity of CP, but induced a concentration-dependent suppression of
Fe2+ auto-oxidation (Fig. 4i–ii). Upon blanking CP against vehicle
auto-oxidation it was apparent that increasing salinity did not alter
the rate of CP activity but lengthened the time before Fe2+ auto-
oxidation was comparable to CP activity; as illustrated when activity
reached a plateau (Fig. 4iii). This lengthening of time effectively allows
a greater window for data collection on CP activity. As a salinity of
150 mM is physiological yet suppresses auto-oxidation, this concentra-
tion was chosen for further experimental conditions.
In summary, the TF loading assay performed adequately in NaOAc
(100 mM, pH 5.5), PIPES (100 mM, pH 6.5) or HBS (50 mM HEPES,
150 mM NaCl, pH 7.2) (Fig. 5Ai–iii), with components of 50 μM
apo-TF, 250 nMCP and 100 μM ferrous sulfate. Within these conditions,
temperature was kept at 24 °C and rate measurements of CP activity
were taken within the ﬁrst 3 min when the rate is in its linear phase
(Fig. 5Bi–iii. respectively).
3.2. Determining iron extinction coefﬁcients in all three ferroxidase assays
using optimal parameters for transferrin loading
The same conditions derived for the “TF loading” ferroxidase assay at
pH 5.5 (NaOAc), 6.5 (PIPES) and 7.2 (HBS) were applied to the two
other ferroxidase assays that measure ferrous loss and ferric gain.
CP-catalyzed ferroxidation was found to be clearly greater than Fe2+
autoxidation in all three assays using these conditions (data not
shown). To validate the reproducibility of results in different spectro-
photometric instruments, the Ferrous Loss assay was studied by titra-
tion of Fe2+. No difference in linear gradient absorbance was observed
between instruments when pathlength-correction was applied (data
not shown). In addition, total volume size after pathlength-correction
did not affect the outcome (data not shown). Therefore, this assay is
obust between instruments as long as absorbance readings are corrected
for pathlength.
The extinction coefﬁcient of ferrous losswas experimentally derived
through a standard curve of Fe2+–ferene S complex in NaOAc, PIPES or
HBS buffers following the Beer–Lambert law. A standard curve of Fe2+
concentration (0–200 μM)was derived at a ﬁxedmolar excess of ferene
S (500 μM). It was noted that varying the concentrations of ferene S at a
constant iron concentration altered the absorbance readout (data not
shown). The assumptions for calculating the extinction coefﬁcient in
this assay were; accuracy of stock FeSO4 concentration and that all Fe2 +
had complexed with ferene S or was in equilibrium before each mea-
surement was taken. The standard curve proceeded linearly untilFerric gain
(mM−1 Fe3+ cm−1)
Transferrin loading
(mM−1 Fe3+ cm−1)
2.30 0.756
1.93 2.28
2.01 2.02
Λmax = 460nm 
10 min
Ai 
B    NaOAc Buffer Titration
D Apo-TF Titration
C     CP Enzyme Titration
E Fe2+ Substrate Titration
Aii 
0 min
Absorption Spectra of various Components
Fig. 1.Optimisation of the transferrin loading assay conducted in sodium acetate buffer pH 6. (A) Absorbance spectra of Fe2+ in the absence or presence of assay components at time point
0 (i) and 10min (ii). Kinetic assay depicting the changes in absorbance at 460 nmwhen sodium acetate (NaOAc; pH 6) (B), CP (C) apo-transferrin (TF) (D) and ammonium ferrous sulfate
(E) are titrated into the assay while the other components are set to the concentrations originally used by Johnson et al. [2]. Results for the ferrous sulfate substrate were identical to
ammonium ferrous sulfate (data not shown). For the TF loading assay in NaOAc pH 6, results in black were selected as the recommended conditions; NaOAc buffer (100 mM), apo-TF
(50 μM), CP (250 nM) and ammonium ferrous sulfate (100 μM). Assays were run at 37 °C and all results with CP present were blanked against appropriate vehicle controls. Individual
data points were mean ± standard error (S.E.) ΔAbs460 of 2 experiments done in duplicates.
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36.6 mM−1 Fe2+ cm−1 in HBS, r2 = 0.999 for all), after which a
plateau was reached due to the ceiling value of the instrument
(Table 1).
Deriving the extinction coefﬁcient of the Ferric Gain assaywas carried
out in an independent assay using the same titration concentrations of
FeSO4 as above. For this assay complete oxidation by CP was required
in the various buffers. To ensure this, absorbance was measured at
310 nmup to 96 h. All endpointmeasurements indicated that the oxida-
tion reaction had gone to completion by 24 h. The standard curve
proceeded linearly for NaOAc (average ε = 2.30 mM−1 Fe2+ cm−1,
r2 = 0.879); PIPES (average ε= 1.93 mM−1 Fe2+ cm−1, r2 = 0.968);
and HBS (average ε= 2.01 mM−1 Fe2+ cm−1, r2 = 0.846) (Table 1).
In NaOAc a titration of FeSO4 without CP did not reach the levels of
oxidized Fe3+ obtained with CP even by 96 h, but in the presence of
PIPES or HBS similar levels of Fe3+ were obtained by auto-oxidation
at intervals longer than 48 h (data not shown).
Similar to the Ferric Gain assay, the extinction coefﬁcients for the TF
loading assay in the various buffers were derived from a titration of
FeSO4 in the presence of TF (50 μM) ± CP. The standard curve
proceeded linearly for NaOAc (average ε= 0.756 mM−1 Fe2+ cm−1,
r2 = 0.808); PIPES (average ε= 2.28 mM−1 Fe2+ cm−1, r2 = 0.969);and HBS (average ε= 2.02 mM−1 Fe2+ cm−1, r2 = 0.971) (Table 1).
As with the Ferric Gain assay, auto-oxidation of Fe2+ in the TF loading
assay was markedly delayed but did eventually reach the same levels
as in the presence of CP (data not shown).
3.3. Characterizing ferroxidase activity using the new combined assay
The ferroxidase activity of CP was determined in a single plate
spectrophotometric assay +/−TF to examine the rate of ferrous loss,
ferric gain and apo-TF loading in parallel using HBS (pH 7.2) buffer to
represent more physiologically relevant conditions than the canonical
characterization [2,20,38,39,42]. The rate of CP ferroxidase activity
without apo-TF was 11.72 ± 0.48 μM Fe3+/min (r2 = 0.984) for
250 nM CP (Fig. 6A), however this rate for CP was greatly enhanced
by the presence of apo-TF (28.96 ± 0.96 μM Fe3+/min, r2 = 0.989).
Apo-TF alone facilitated iron oxidation (2.85 ± 0.24 μM Fe3+/min,
r2 = 0.934) (Fig. 6B), compared to vehicle alone (0.348 ±
0.08 μM Fe3+/min, r2 = 0.673) as previously reported [45,49]. Upon
correcting for oxidation in the presence of apo-TF only, the rate of CP
ferroxidase activity in the presence of TF was still more than twice the
rate of CP ferroxidase without TF (26.10 ± 1.00 μM Fe3+/min). This
indicated that there is cooperation between CP and TF. The addition of
A Low pH B Neutral pH C Physiological pH
and salinity
Fig. 2. Buffer effects on transferrin loading assay. Buffers were grouped according to pH and salinity with low pH (100 mM buffer) ranging from pH 5.5–6 and no NaCl (A), neutral pH
(100mMbuffer) at pH 7.0 and noNaCl (B), and physiological pH (50mMbuffer) at pH 7.2–7.4with 150mMNaCl (C). Results in black indicate suitable buffers for the transferrin loading
assay with all other components required for the assay ﬁxed at the ﬁnal concentrations determined in Fig. 1, but the assaywas performed at 24 °C to slow the rate of oxidation. Individual
data points were means ± S.E. ΔAbs460 of 1 experiment done in triplicates.
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served to conﬁrm results observed in the Ferric Gain and TF loading as-
says. After 3 min 35.2 μM Fe3+ was detected by the Ferric Gain assay
compared to 44.1 μM Fe3+ in the Ferrous Loss assay (Fig. 6A & C). This
~10 μM Fe3+ discrepancy may have been caused by the delay taking
the plate out of the spectrophotometer and manually adding the ferene
S chromogen. Fe3+ between TF loading and Ferrous Loss assays
was more comparable (86.9 μM Fe3+ and 87.1 μM Fe3+ respectively)
(Fig. 6B & D). Taken together, these results conﬁrm that the combined
ferroxidase assay is robust, quantitative and comparable between
individual assays.3.4. Enzyme kinetic characterization of ceruloplasmin
Utilizing the new combined assay in a physiologically appropriate
buffer (i.e. HBS pH 7.2), Michaelis–Menten enzyme kinetics of CP
ferroxidase activity was calculated. As expected for an enzymatic reac-
tion, the velocity of CP followed a non-linear regression curve for Ferric
Gain and TF loadingwhereas auto-oxidation proceeded linearly (Fig. 7A
& B). In the TF assay, the linear progression of auto-oxidation eventually
intersected the regression curve of CP catalyzed oxidation at ~400 μM
Fe2+ (Fig. 7B). When CP activity was blanked against the appropriate
controls, including auto-oxidation, the rate measurements yielded
similar Km values for Ferric Gain and TF loading, but Vmax
values that were slightly different (Ferric Gain: Vmax = 38.96 ±
1.33 μM Fe3+/min/μM CP; Km = 15.07 ± 2.07 μM vs. TF loading:
Vmax = 33.83 ± 2.06 μM Fe3+/min/μM CP; Km = 15.68 ± 3.73 μM)
(Fig. 7C, D). A caveat in the accuracy of enzyme kinetics from the TF
loading assay is that the readoutmay have been distorted by transferrineither detecting continual competition for Fe2+ by auto-oxidation
or facilitating oxidation.
Within our experimental parameters, we also investigated the
effects TF may have on CP. By TF loading assay, TF alone promoted
Fe2+ oxidation at pH 7.2 (Fig. 7A & B). However, because the velocity
of this activity proceeded linearly in a substrate-dependent manner,
the velocitywasmore akin to a depletion of substrate (Fe2+) and subse-
quent shift of equilibrium to increased consumption of products rather
than catalysis by an enzyme.
3.5. Inhibition of ceruloplasmin by azide
Azide has previously been reported to inhibit CP amine oxidase
activity in vitro [50] and the fraction of the ferroxidase activity repre-
sented by CP in serum/plasma [51]. However, as far as we are aware,
the inhibition by azide on the ferroxidase activity of CP in vitro has
yet to be evaluated. Using the combined ferroxidase assay in HBS
(pH 7.2), at a ﬁxed substrate concentration of Fe2+ (50 μM), azide
was shown to efﬁciently inhibit CP (250 nM) ferroxidase activity with
an IC50 of azide at ~40 μM for Ferric Gain and ~50 μM for the TF loading
(Fig. 8A & B).
Previous work on azide inhibition of the amine oxidase activity of CP
has indicated uncompetitive inhibition whereby azide directly inhibits
the enzyme-substrate complex or forms a complex with CP that inca-
pacitates its activity [50]. Using Lineweaver Burk plots with increasing
inhibitor concentrations, we similarly model uncompetitive inhibition
by azide in both Ferric Gain and TF loading assays (Fig. 8C & D). The
inhibitory constant (αKi) (inhibitor to enzyme binding) was derived
from the product of the binding constant of azide to CP (Ki) and Fe2+
to CP (α) as these are unable to be accurately ﬁtted separately for
i CP ii Vehicle Control iii Blanked CP- =
Di 
A
B  
C
Dii 
Fig. 3.pHeffects in optimal buffers for transferrin loading assay. pHvariance on the TF loading assaywas investigated in the suggested bufferswith low, neutral andphysiological pH range
(see Fig. 2). NaOAc (100mM) at pH 4.5–5.5 (A), PIPES (100mM) at pH 6.5–7.5 (B) and HBS (50mMHEPES, 150mMNaCl) at pH 7.0–8.0 (C)were assayed in the presence of CP (250 nM)
(i), the corresponding vehicle control (ii) and with CP blanked against the vehicle control (iii). The results in black indicate the recommended pH for each buffer with the ﬁnal
concentrations of the other assay reagents kept constant and the assay ran at 24 °C. The rate of CP activity was plotted at pH 4.5–8.0 (NaOAc, pH 4.5–5.5; PIPES, pH 6.5–7.0; and HBS,
pH 7.0–8.0) before (Di) and after (Dii) subtraction of auto-oxidation (shown as vehicle control, Veh, in Di). Experiments were conducted twice with individual data points of the graphs
representing means ± S.E. ΔAbs460 shown is of 1 representative experiment of 3, with data points as the mean of triplicate readings.
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not obey the assumptions of linear regression (due to distortion of ex-
perimental error), Vmax, Km and αKi were calculated using non-linear
regression (Fig. 8E & F Table 2). Azide as an uncompetitive inhibitor
did not bind to the enzyme CP as signiﬁed by the high Ki (Ferrici CP ii Vehicle Con-
Fig. 4. Effect of varying salinity in HBS for transferrin loading assay. Salinity in HBS (pH 7.2) on
(250 nM) (i), the corresponding vehicle control (ii) andwith CP blanked against the vehicle con
with all other assay reagents at previously determined concentrations, at 24 °C. As physiologica
for 200mMNaCl, experiments were conducted twice with individual data points of the graphs
points as the mean of triplicate readings.Gain was 78.3 ± 47.8 μM and Ki for TF loading was 8.1 × 104 ±
7.5 × 104 μM), whileαwas low indicating that azide enhanced substrate
Fe2+ binding to enzyme CP (Ferric Gain: 0.39 ± 0.26 and TF loading: 4.1
× 10−4 ±0.38). The model that best ﬁts these results thus conﬁrms the
uncompetitive inhibition of azide on CP that was illustrated by thetrol iii  Blanked CP=
the TF loading assay was investigated between 0 and 200 mM NaCl in the presence of CP
trol (iii). The results in black indicate themost suitable salinity to be close to 200mMNaCl
l levels of salinity are ~150mM, andwould provide similar rates of activity for CP as shown
representingmeans± S.E.ΔAbs460 shown is of 1 representative experiment of 3, with data
A
i NaOAc pH 5.5 ii PIPES pH 6.5 iii HBS pH 7.2
B
Fig. 5. Recommended conditions selected for the transferrin loading assay. Over a broad pH range the recommended reagent concentrations for the TF loading assay were 50 μM apo-TF
250 nMCP and 100 μM ferrous sulfate.With low pH, the assay had similar conditions to those originally proposed by Johnson et al. [2], but the pH needed to be lowered to 5.5 in order for
NaOAc to be within its buffering range (Ai). At higher pH the best conditions were PIPES (Aii) and in the presence of saline, HBS (pH 7.2, 150 mM NaCl) (Aiii). Upon blanking enzymatic
activity against vehicle auto-oxidation the recommended time for measuring kinetics at 24 °C in all buffers waswithin the ﬁrst 3 min (as shown in black) when enzymatic rate was linear
(B). Individual data points of the graphs were means ± S.E. ΔAbs460 shown is of 1 representative experiment of 3, with data points as the mean of triplicate readings.
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competitive auto-oxidation in the TF loading assaymeans that the inhibi-
tion kinetics from the Ferric Gain assaymay bemore accurate (Fig. 8G, H).
3.6. Minimizing other forms of variability in the ferroxidase assay
Consistency in the preparation of the enzyme studies in the assay
was paramount for obtaining reliable kinetics. As an example, CP asC       Ferrous loss
A        Ferric gain
D   F
B       
0 
40 
80 
120 
CP CP +
Azide 
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Azide 
Fe
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Fig. 6. Ceruloplasmin activity in the triplex ferroxidase assay. Kinetic measurements of CP ferr
amount of Fe3+ produced over 3 min; and (B) the amount of Fe3+ loaded onto apo-TF over 3
selective chromogen ferene S, which measured the amount of Fe2+ remaining after ferroxidas
various assay componentswere: HBS buffer (50mMHEPES, 150mMNaCl, pH 7.2); CP (250 nM
was constant at 24 °C throughout the assay. Results in (A) and (B) were blanked against the rea
data points shown are means ± S.E., n = 3 of a representative experiment carried out 3 timesprovided by the manufacturer was found to contain trace amounts of
EDTA that anomalously alter ferroxidase measurements in the assay.
Chromatographic exchange of the enzyme buffer to the optimal buffer
used in the assay alleviated the inhibitory effect of EDTA previously
observed (data not shown).
Similarly, trace contaminants of electrolytes were observed to have
varying consequence on ferroxidase activity in the assay. Up to a
concentration of 10 mM, sulfate had little effect in the assays, but theerrous loss + TF
  TF loading 
 
 
 
 
CP CP +
Azide 
Veh Veh +
Azide 
*
oxidase activity and inhibition with sodium azide were calculated by quantifying (A) the
min. Endpoint measurements of CP ferroxidase activity at 4 min after addition of a Fe2+
e conversion in the absence (C) or presence (D) of transferrin. Final concentrations of the
); sodiumazide (1mM); FeSO4 (100 μM); and apo-TF (50 μM)(only B andD). Temperature
ding at the ﬁrst time point. This experiment was performedmultiple times. The individual
.
Vmax = 38.96 ± 1.33 [Fe3+]µM/min/[Cp]µM 
Km = 15.07 ± 2.07 [Fe2+]µM 
Kcat = 0.649 ± 0.022 sec-1
Kcat/Km = 4.3 × 104 sec-1M-1
Vmax = 33.83 ± 2.06 [Fe3+]µM/min/[Cp]µM
Km = 15.68 ± 3.73 [Fe2+]µM 
Kcat = 0.564 ± 0.034 sec-1
Kcat/Km = 3.4× 104 sec-1M-1
C D 
A Ferric gain B Transferrin loading 
Fig. 7.Characterizing the enzyme kinetics of ceruloplasminwith FerricGain and transferrin loading assays run concurrently. Plots representing raw kinetics blanked against 0 μMsubstrate
of both CP activity and vehicle control auto-oxidation for (A) Ferric Gain, and (B) transferrin loading. Michaelis–Menten enzyme kinetics of CP blanked against auto-oxidation was
measured by Ferric Gain (C) and TF loading (D). Conditions of the assays were as previously described at varying substrate concentrations (FeSO4 0–200 μM). The individual data points
shown are means ± S.E., n = 3 of a representative experiment, n = 2.
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Ferric Gain assay) as well as TF loading, and bicarbonates increased TF
loading only (Fig. 9). This would explain the increased TF loading in
PBS observed in Figs. 2 and S2. Cations Na, K, Ca and Mg up to 10 mM
had no effect on the Ferric Gain or TF loading assays (data not shown).
4. Discussion
For nearly 50 years the TF assay has been widely considered by
biologists as an idealmethod formeasuring ferroxidase activity because
it emulates a physiological transfer. However, since the assay was pub-
lished, doubts about its accuracy in measuring kinetic enzyme activity
have arisen because it relies on an indirect colorimetric readout of
holo-TF, and TF interaction may impact on the enzyme's activity. A
further concern has been the use of non-physiological low pH, in
order to reduce auto-oxidative interference in this classical assay.
Therefore, we investigatedwhether the assay could bemodiﬁed tomea-
sure enzymatic activity of a ferroxidase under physiological conditions,
as well as providing internal controls to ensure authentic ferroxidase
kinetics.
4.1. Optimal parameters for measuring ferroxidase activity
Upon evaluating the existing parameters used for the TF loading
assay, enzyme, TF, substrate and buffer concentrations were all found
to be within an acceptable range to measure ferroxidase activity
(Fig. 1). However, the pH 6.0 used for NaOAc buffer was outside its
optimal buffering range (3.6–5.6) and thus alternative buffers were
identiﬁed according to their buffering capabilities at low pH, neutral
pH and physiological pH. While NaOAc was still considered the best
buffer to use once in its correct buffering range (pH 5.5), Good's buffers
PIPES and HEPES were recommended for neutral and physiological
pH respectively. With increasing alkalinity ferroxidase activity was
augmented, resulting in enhanced sensitivity, however beyond pH 7
the background auto-oxidation rate also increased exponentially
and impaired accurate enzymatic rate readings (Fig. 3Di). Increasingsalinity in the reaction signiﬁcantly reduced auto-oxidation rate above
pH 7, while minimally affecting ferroxidase activity (Fig. 4). Increasing
the salinity of the reaction had the additional beneﬁts of providing
a more physiologically relevant environment as well as slowing
the enzymatic reaction, which permitted more accurate kinetic
readings.
Within the same physiological buffer, additional recommended
requisites for measuring enzymatic activity are: (A) an assay tempera-
ture of 24 °C instead of 37 °C to slow completion of iron oxidation to
N5 min, facilitating kinetic monitoring, (B) elimination of contaminants
such as anions or chelators that can affect enzymatic activity (Figs. 2 and
9), (C) auto-injection of substrate and immediate spectrophotometric
measuring to minimize discrepancies between reaction start times,
and (D) selecting data within the ﬁrst 3 min of the kinetic assay to en-
sure that the reaction is within its linear rate (Fig. 5Bi–iii).
Experimentally deriving extinction coefﬁcients using the recom-
mended conditions for assays of Ferric Loss, Ferric Gain and the amount
of Fe3+ loaded onto TF gave us more precise measurement of iron
product concentrations (Table 1). Extinction coefﬁcients at 465 nm for
diferric-, C-terminal monoferric- and N-terminal monoferric TFs were
previously determined as 4.86, 2.78 and 2.08 mM−1 cm−1 respectively
[53] whereas at 460 nm diferric-TF has previously been calculated as
4.56 mM−1 cm−1 [39]. In our conditions with PIPES and HBS buffer,
the amounts of Fe3+ loaded onto TF at 460 nm were 2.28 and
2.02mM−1 cm−1 respectively. These values relate well with the extinc-
tion coefﬁcients previously reported for monoferric TF [53], without
discerning for terminal TF loading, and suggest that the extinction coef-
ﬁcients for Fe3+ correspond better withmonoferric TF formation rather
than diferric TF in physiological conditions and excess TF. Of relevance
to the original assay conditions, we were unable to accurately derive
an extinction coefﬁcient for the TF loading assay in NaOAc buffer
pH 5.5 (0.756 mM−1 cm−1; Table 1) despite extinction coefﬁcients for
Ferrous Loss and Ferric Gain assays being comparable within all three
buffers. This suggests that at low pH, TF is unable to be suitably loaded
with Fe3+, resulting in an underestimation of Fe3+ production in the
previous literature that has used this protocol.
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Fig. 8. Characterizing azide inhibition of ceruloplasmin. Sodium azide concentration (0–100 μM)was plotted against the amount of Fe3+ converted by CP within 3 min as determined by
(A) Ferric Gain or (B) TF loading assays. Lineweaver–Burk (C & D) and a representative nonlinear regression graphical model (E & F) of CP ferroxidase kinetics inhibited by sodium azide
were calculated by Ferric Gain and TF loading assays, respectively. Enzymatic kinetics of (G) CP and (H) vehicle alonewere determined by transferrin loading assay at 24 °C in the presence
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means ± S.E., n = 3 of a representative experiment, n = 2.
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This novel three-in-one ferroxidase protocol has the advantage of
simultaneously measuring the ability of a ferroxidase to reduce levels
of the substrate Fe2+, its conversion to Fe3+ and the physiological
uptake by apo-TF. The requirement of ferene S to measure ferrous loss
meant that this part of the assay is only used as the end point control
for Fe2+ consumption during the ferroxidase reaction. Whereas the
Ferric Gain assay directly measures Fe3+ conversion over time and
therefore can be implemented for the most accurate measurement of
enzyme kinetics and inhibition constants involved with a ferroxidase.The dissociation constant of Fe3+ bound to TF is approximately
1022 M−1 at pH 6.0 [54] and was utilized to indirectly measure iron
bound to TF as the product. TF afﬁnity for Fe2+ is known to be a lot
weaker, but no direct binding data is currently available despite
estimates ranging from log K 2.5–3.7, depending on the binding sites
on TF [55,56]. Whether Fe2+ is oxidized before or after uptake into TF
(as illustrated in Eqs. (4) and (5)) is yet to be identiﬁed and the focus
of our future research. Either way, the association of iron with TF
could directly affect oxidation rate. Our results on CP kinetics indicate
that, at least in the initial substrate concentrations, TF loading
proceeded at almost identical Km as that of Ferric Gain (Fig. 7). This
Table 2
CP enzyme kinetics and azide inhibition constants.
Global Ferric Gain assay Transferrin loading assay
Vmax
(μM Fe3+/min/μM CP)
39.3 ± 1.1 32.6 ± 2.3
Km
(μM Fe2+)
16.3 ± 1.7 18.4 ± 5.2
αKi
(μM azide)
27.4 ± 1.6 33.2 ± 4.8
3308 B.X. Wong et al. / Biochimica et Biophysica Acta 1840 (2014) 3299–3310suggests that the Ka of TF and iron is much higher than the Km and
thus not rate limiting. TF loading measurements are also affected by
increased auto-oxidative rate at pH 7.2 which resulted in decreased
velocity with increased substrate concentrations as the rate of auto-
oxidation begins to approach the ferroxidation rate. While these com-
plications raise doubts into its use for measuring ferroxidase kinetics,
the study of ferroxidase activity as a function of TF loading is especially
revealing in regard to the mechanism of diferric TF formation by an
enzyme and therefore provides important additional information
under physiological conditions.4.3. Kinetics for ceruloplasmin activity and inhibition by sodium azide
within physiological parameters
In vitro enzyme kinetics of puriﬁed CP have previously been investi-
gated as a function of oxygen consumption [38], oxidation of N,N-
dimethyl-p-phenylenediamine (DPD) [57] and the non-kinetic forma-
tion of diferric TF [33]. As far as we are aware, this is the ﬁrst time the
ferroxidase kinetics of CP has been described under physiological condi-
tions following the direct production of Fe3+ and it's loading onto TF.
The most direct comparison of CP enzyme kinetics to our assay is by
oxygen consumption conducted in acetate buffer at a pH outside
acetate's buffering range (pH 7) [38]. Despite this their Vmax and KmA  Ferric gain
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62.9 μM O2/min/μM CP and Km 18.2 μM O2).
A direct quantiﬁcation of the inhibitory kinetics of sodium azide on
CP ferroxidase activity has also, to our knowledge, not been reported
previously, although there are reports of the inhibitory effect of azide
on the amine oxidase activity of CP using p-phenylenediamine as a sub-
strate [50], and of the inhibitory effect of azide on serum ferroxidase ac-
tivity (assumed to originate from CP) by TF loading assay [51]. 3 μM
azide was reported to inhibit 50% of 380 nM CP amine oxidase activity,
however our results demonstrated that azide has 20–25 fold less poten-
cy at inhibiting CP ferroxidase activity, consistentwith the differences in
the reaction mechanisms between the amine oxidase and the ferroxi-
dase activity of CP.
4.4. Implications for measuring ferroxidase activity in a biological
environment
Anions such as bicarbonates and phosphates accelerate iron oxida-
tion, as well as promote Fe3+ loading into TF. This could be a source
of artifact in ferroxidase assays in buffers containing these anions
(e.g. PBS) or in biological ﬂuids. As detailed here, controls are required
to eliminate the non-enzymatic component when measuring activity
in biological samples and may explain the identiﬁcation of a ‘small
molecular ferroxidase’within biological samples [20,21].
In synergy with an anion, TF can bind a variety of metal ions such as
Fe3+, Al3+ and Cu2+ with variable afﬁnity. It is proposed that the anion
serves as a bridging ligand between themetal and TF [58–60], and in so
doing excludes water from two coordination sites [54,61]. In the pres-
ence of an anion, ferric-TF is resistant to almost all but the strongest che-
lators, but without the anion Fe3+ binding to TF is negligible. Carbonate
is the naturally occurring synergistic anion that forms the strongest
metal complexes with TF [58], however, other biologically relevant an-
ions are able to act similarly, depending on their size and the presences
of a carboxylate group that brings together TF and Lewis base atoms
(i.e. oxygen, nitrogen or sulfur) to interact with the metal [58,61–65].)
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3309B.X. Wong et al. / Biochimica et Biophysica Acta 1840 (2014) 3299–3310It is widely considered that a ferroxidase facilitates the efﬂux of
cellular iron. In the presence of CP, it has been demonstrated that the
enzyme not only stabilizes the iron efﬂux pore, FPN, on the cell surface
but also facilitates the release of Fe2+ within the pore through the
safe oxidation to Fe3+ and its incorporation into apo-TF present in the
interstitial ﬂuid surrounding the cell. However, in light of our current
ﬁndings, and considering existing knowledge described above, it is pos-
sible that if a protein is able to stabilize FPN on the cell surface then fer-
roxidase activity from the sameproteinmay not always be necessary for
iron efﬂux. In a normal physiological environment, levels of bicarbon-
ates and phosphates surrounding the cell are high enough to enable
the oxidation of iron at the exit of the FPN pore, as well as to load
holo-TF. The observation that a higher anion gap and lower bicarbonate
level are associatedwith higher ferritin levels in a study of 4525 healthy
adults [66] supports this possibility. While this non-enzymatic reaction
is likely to produce hydroxyl radicals, anti-oxidant buffering in place
within the extracellular environment would be more than capable of
negating their potential to cause oxidative damage. However, in situa-
tions of high oxidative stress or where high rates of cellular iron efﬂux
are required, a ferroxidase such as CP may be essential to safely remove
intracellular iron. Our data support the proposition by Kosman [19] that
dual routes of cellular iron efﬂux may exist: a ferroxidase route for
expedited removal of iron from FPN with incorporation into TF, and a
passive, non-enzymatic route that only requires a membrane bound
protein to stabilize FPN on the surface but capitalizes on the oxidative
capability of anions within the extracellular environment to facilitate
iron release from FPN and incorporation into TF. Further research is
currently underway to investigate the biological viability of this second
iron efﬂux model and the pathological relevance of its impairment in
disease.
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